l carnitine tmao nature medicine 2013 koeth γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of L-carnitine to The microbial metabolite trimethylamine N-oxide
The microbial metabolite trimethylamine N oxide promotes antitumor immunity in triple negative breast cancer: Cell Metabolism A Multi omic Association Study of Trimethylamine N Oxide ScienceDirect TMAO: how gut microbiota contributes to heart failure Translational Research A systematic review of TMAO, microRNAs, and the oral gut microbiomes in atherosclerosis and myocardial infarction: mechanistic insights and translational opportunities Journal of Translational Medicine Springer Nature Link Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO ScienceDirect
Pay in 4 interest-free payments of $7.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




